This finding might imply a relationship between serum zonulin levels and disease severity in HT, because in patients with CH, levothyroxine dose is mainly based on the amount of residual thyroid tissue/function, age, body weight, and thyroid hormone levels (16). This evidence concerns the gene HP and hematocrit.